AAIC 2025 Abstract
Imaging‐based biological staging associates with brain atrophy in preclinical Alzheimer's disease
By Lorenzo Fontura Brasil Barcellos, João Pedro Ferrari-Souza, Isabela Just de Jesus Vanni, Show 20 more authorsEduardo Rigon Zimmer
Study in peopleBiomarkers
Abstract
Background: Alzheimer's disease (AD) diagnostic and staging criteria rely on imaging biomarkers as robust tools for in vivo disease assessment. Among these, cortical brain atrophy is recognized as a key hallmark of disease progression.
